Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Scand J Immunol ; 60(6): 625-30, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15584974

ABSTRACT

A soluble form of the complement receptor CD21 (sCD21) is shed from the lymphocyte surface. The amount of sCD21 in serum may modulate immunity as sCD21 levels are correlated with several clinical conditions. We report here the serum levels of sCD21 in juvenile arthritis (JA), systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). Using enzyme-linked immunosorbent assay, we determined sCD21 levels in SLE, SS and JA patients. Mann-Whitney test for nonparametric two-tail P value was performed to obtain statistical significance. Cytometrical analysis of synovial fluid leucocytes of JA patients was done on a FACSsort. While sCD21 levels in SLE and SS are reduced to levels previously found in rheumatoid arthritis (RA), JA sCD21 levels were normal. sCD21 levels did not correlate with clinical parameters and immunophenotype of synovial cells. CD4 T cells in the synovium were almost all of the CD45RO memory type and 13 of 40 patients displayed synovial expansion of gammadeltaT cells. CD21 shedding in JA differs from RA/SS/SLE. JA sCD21 levels in synovial fluid are always lower compared to blood levels of the same patients. Analysis of JA synovial T cells indicates a T-cell driven response.


Subject(s)
Arthritis, Juvenile/metabolism , Lupus Erythematosus, Systemic/metabolism , Receptors, Complement 3d/metabolism , Sjogren's Syndrome/metabolism , Humans
2.
Scand J Immunol ; 60(4): 403-11, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15379865

ABSTRACT

We investigated the effect of pressure levels ranging from 80 to 500 bar on the proliferative capacity and viability of Jurkat leukaemic T cells. Pressurization at 360 bar induced apoptotic cell death as shown by apoptotic morphology after Hoechst staining, DNA fragmentation in the TdT-mediated dUTP nick end labelling-assay and cleavage of several caspase substrates. Cell death could be prevented by the general caspase inhibitor zVAD-fmk. Breakdown of the mitochondrial membrane potential and the release of cytochrome c provided strong evidence for an involvement of the mitochondrial pathway, whereas a central role of the death receptor pathway was excluded because caspase-8 was not significantly activated. Pressure incubation led to calcium influx after 5 min, and we hypothesize that calcium influx could be the primary trigger for pressure-induced apoptosis.


Subject(s)
Apoptosis/physiology , Hydrostatic Pressure/adverse effects , Mitochondria/metabolism , Amino Acid Chloromethyl Ketones/pharmacology , Apoptosis/drug effects , Calcium Signaling , Caspase 8 , Caspase Inhibitors , Caspases/metabolism , Cysteine Proteinase Inhibitors/pharmacology , DNA Damage , Humans , Jurkat Cells , Leukemia, T-Cell/metabolism , Leukemia, T-Cell/pathology
3.
Rheumatology (Oxford) ; 43(2): 186-90, 2004 Feb.
Article in English | MEDLINE | ID: mdl-12867574

ABSTRACT

OBJECTIVE: The soluble cluster of differentiation 21 (sCD21) represents the extracellular portion of the CD21 glycoprotein and is released by shedding from cell surfaces into plasma. Soluble CD21 binds complement fragments and activates monocytes through binding to membrane CD23. Elevated levels of sCD21 are found during Epstein-Barr virus EBV infections, B-cell lymphoma and other lymphoblastoid tumours. The present study was undertaken to investigate levels of sCD21 in rheumatoid arthritis. METHODS: A specific enzyme-linked immunoassay was developed using sCD21, biochemically purified to homogeneity from human plasma as a standard for the determination of sCD21 concentration in patient sera. Peripheral blood B and T lymphocytes were isolated from healthy donors and rheumatoid arthritis patients and cultured, and supernatants were analysed for CD21 shedding. RESULTS: The normal values of serum sCD21 in healthy individuals between 20 and 40 yr of age ranged from 100 to 477 ng/ml (median 292 ng/ml), decreasing with age but not differing with gender. In rheumatoid arthritis patients, sCD21 levels ranged from 50 to 300 ng/ml (median 182 ng/ml), did not differ with age and were independent of rheumatoid factor. CONCLUSIONS: In contrast to healthy donors, patients with rheumatoid arthritis have significantly lower sCD21 levels (P < 0.0001), independently of the age of the patients. Sorted B cells from rheumatoid arthritis patients released amounts of CD21 comparable with those of normal controls. Possible causes and consequences of the findings are discussed.


Subject(s)
Arthritis, Rheumatoid/immunology , Receptors, Complement 3d/blood , Adolescent , Adult , Aged , Aged, 80 and over , Aging/immunology , B-Lymphocytes/immunology , Cells, Cultured , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Infant , Male , Middle Aged , Reference Values , Solubility , T-Lymphocytes/immunology
5.
Rheumatol Int ; 20(4): 133-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11411956

ABSTRACT

The complement receptor II (CD21) recognises the complement component C3d of immune complexes. Expression of the CD21 gene is tightly regulated during B lymphocyte differentiation. Only mature B lymphocytes express CD21 but not pro-, pre-, or plasma B lymphocytes. Previously we found that pro-, pre-, and intermediate B lymphocytes contain a methylated CpG island and do not express CD21. CD21-expressing mature B lymphocytes, plasma B lymphocytes, and nonlymphoid cells carried a demethylated CD21 CpG island. Furthermore, we found that synovial lymphocytes from patients with rheumatic disease show reduced expression of CD21. This observation tempted us to analyse the methylation status of the CD21 CpG island in peripheral blood mononuclear cells and synovial fluid mononuclear cells derived from these patients. While methylation is involved in silencing CD21 in early types of B lymphocytes, we found the CD21-CpG island to be demethylated in peripheral blood mononuclear cells and synovial fluid mononuclear cells of patient DNA.


Subject(s)
B-Lymphocytes/metabolism , Complement C3d/genetics , CpG Islands/physiology , DNA Methylation , Monocytes/metabolism , Receptors, Complement 3d/metabolism , Synovial Fluid/cytology , Aged , Arthritis, Reactive/genetics , Arthritis, Reactive/immunology , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Cells, Cultured , DNA Primers , Female , Flow Cytometry , Gene Expression Regulation , Humans , Male , Middle Aged , Promoter Regions, Genetic , Sensitivity and Specificity , Synovial Fluid/metabolism
6.
Int Immunol ; 13(5): 705-10, 2001 May.
Article in English | MEDLINE | ID: mdl-11312258

ABSTRACT

The complement receptor II (CD21) serves as a receptor for the complement component C3d of immune complexes on B lymphocytes. Expression of the CD21 gene is tightly regulated during B lymphocyte differentiation. Only mature B lymphocytes, but not pro-, pre- or plasma B lymphocytes, express CD21. There is evidence that cell type-specific expression is mediated by a silencer element located in the first intron. The CD21 promoter region contains a CpG island adjacent to the ATG start codon. We have analyzed the methylation status of this CpG island in B lymphoid cell lines representing the various differentiation stages of B lymphocyte development and primary lymphocytes. We found that the pro-, pre- and intermediate B lymphocytes contain a methylated CpG island and do not express CD21, whereas CD21-expressing mature B lymphocytes, plasma B lymphocytes and non-lymphoid cells carry a demethylated CD21 CpG island. To analyze whether the lack of CD21 expression in early B lymphocytes is due to inhibition by CpG methylation we have used 5-aza-2'-deoxycytidine to inhibit DNA methyltransferase activity. Treatment of pro-B lymphocytes with the drug resulted in expression of CD21. We have also applied Trichostatin A (TSA), an inhibitor of histone deacetylation, to determine whether the state of histone deacetylation affects the expression of CD21. We found that TSA induces expression of CD21 in early B lymphocytes. Thus CD21 expression is controlled by both methylation of the CD21 CpG island and chromatin modification through histone deacetylation in early B lymphocyte development.


Subject(s)
Receptors, Complement 3d/genetics , Acetylation , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Base Sequence , Cell Differentiation , CpG Islands , DNA Methylation , DNA Primers/genetics , Gene Expression Regulation , Histones/metabolism , Humans , Lymphocyte Activation , T-Lymphocytes/immunology , T-Lymphocytes/metabolism
7.
Immunobiology ; 202(4): 353-62, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11131152

ABSTRACT

The CD8 glycoprotein serves as a coreceptor for T cell receptor (TCR)-mediated recognition of peptides associated to MHC class I. In CD8alpha deficiency, MHC class-I restricted cytotoxic T lymphocytes (CTL) are absent and lineage commitment to CD8 cells is impaired. We described a pharmacological approach to reduce the amount of CD8 surface glycoproteins on human peripheral blood T cells. Using calyculin A, a potent inhibitor of protein phosphatases, we were able to down regulate both CD8alpha protein and mRNA. Reduction of CD8alpha surface expression was dose- and time-dependent. The effect was specific to CD8alpha in that CD4 expression was not affected and specific for calyculin A. Okadaic acid, another phosphatase inhibitor did not show any influence on the expression of CD4 or CD8.


Subject(s)
CD4 Antigens/biosynthesis , CD8 Antigens/biosynthesis , Enzyme Inhibitors/pharmacology , Oxazoles/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , T-Lymphocytes/immunology , Blotting, Western/methods , CD8 Antigens/genetics , Cells, Cultured , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Humans , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Marine Toxins , Okadaic Acid/pharmacology , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , Time Factors , Transcription, Genetic/drug effects
8.
Clin Exp Immunol ; 122(2): 270-6, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11091285

ABSTRACT

The expression of CR2 (CD21) by synovial B and T lymphocytes of patients suffering from various forms of arthritis was analysed with cytofluorometry and with reverse transcriptase-polymerase chain reaction. CR2 (CD21) cell surface protein was detected in normal quantities on peripheral B cells, but was almost absent on synovial B lymphocytes of the same patients. This reduction was most severe in patients with rheumatoid arthritis, but also observed in all other cases. CR2 (CD21) did not reappear after in vitro culture. CR2 (CD21) mRNA was also strongly reduced in synovial B and T lymphocytes. Synovial fluid B lymphocytes were larger than peripheral blood B lymphocytes, while T cells from the same patients showed no size differences. We conclude that synovial fluid B lymphocytes have undergone an irreversible step towards terminal differentiation. The presence or absence of CR2 (CD21) mRNA in peripheral versus synovial T cells indicates that CR2 (CD21) is also differentially expressed by T lymphocytes.


Subject(s)
Arthritis/immunology , B-Lymphocytes/immunology , Receptors, Complement 3d/metabolism , Synovial Fluid/immunology , T-Lymphocytes/immunology , Adult , Arthritis/genetics , Arthritis, Psoriatic/genetics , Arthritis, Psoriatic/immunology , Arthritis, Reactive/genetics , Arthritis, Reactive/immunology , Arthritis, Rheumatoid/genetics , Arthritis, Rheumatoid/immunology , Base Sequence , Case-Control Studies , DNA Primers/genetics , Gene Expression , Humans , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Complement 3d/genetics , Spondylitis, Ankylosing/genetics , Spondylitis, Ankylosing/immunology , Still's Disease, Adult-Onset/genetics , Still's Disease, Adult-Onset/immunology , Synovial Fluid/cytology
9.
Eur J Immunol ; 30(4): 1069-77, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10760795

ABSTRACT

Common variable immunodeficiency (CVID) is characterized by defective B cell maturation and antibody formation resulting in low serum antibody levels of most or all Ig isotypes. A specific subgroup of patients ("type A") has normal numbers of mature surface (s)IgM / sIgD- positive circulating B cells. However, since these lymphocytes do not respond to in vitro stimulation by differentiation and Ig synthesis, they seem to suffer from so far unknown intrinsic defects. Analyzing the expression pattern of a large set of B cell activation-specific surface markers, we found that type A CVID patients show a highly reduced expression of the CD28 / CTLA-4 ligand CD86 (B7-2) and of the lymphocyte activation marker CDw137 when compared to B cells of healthy donors and non-type-A CVID patients. The lowered CD86 expression levels were found to correlate with reduced levels of CD86 mRNA. Since combined stimulation via B cell antigen receptor and CD40 cross-linking did not rescue the defects in CD86 and CDw137 expression, B cells of CVID type A patients resemble functionally unresponsive lymphocytes incapable of cooperating with T cells. The fact that these cells accumulate in type A CVID patients suggests a causal relationship with the pathogenesis of this disease.


Subject(s)
Antigens, CD/metabolism , B-Lymphocytes/metabolism , Common Variable Immunodeficiency/classification , Common Variable Immunodeficiency/metabolism , Membrane Glycoproteins/metabolism , Adult , Aged , Antigens, CD/genetics , B-Lymphocytes/immunology , B-Lymphocytes/pathology , B7-2 Antigen , CD40 Antigens/immunology , Cells, Cultured , Child , Common Variable Immunodeficiency/immunology , Common Variable Immunodeficiency/pathology , Down-Regulation , Female , Flow Cytometry , Humans , Lymphocyte Activation/immunology , Male , Membrane Glycoproteins/genetics , Middle Aged , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor Aggregation , Receptors, Antigen, B-Cell/immunology , Up-Regulation
10.
Anal Cell Pathol ; 19(2): 99-103, 1999.
Article in English | MEDLINE | ID: mdl-10746440

ABSTRACT

Staining multiple samples for data acquisition with a flow cytometer is done in 96-well plates to save time and make large data assessment in one working day possible. However, the inability of the FACScan to take up the samples from 96-well plates is a major drawback. In order to avoid the individual transfer of samples to tubes, we have developed a system, which allows using the FACScan with 96-well plates. The machine consists of a programmable control module and a loader which moves the 96-well plate in 3 axis well by well along the sample collector. The machine is equipped with a wash buffer tank to avoid cross contamination of samples and a shaking option to avoid sedimentation of cells during acquisition. The machine can be further developed into a full automatic loader if connected to the FACS Station. In 24 hours about 7,000 samples with 10,000 cells each can be acquired.


Subject(s)
Flow Cytometry/instrumentation , Pathology/instrumentation , Humans , Image Processing, Computer-Assisted/instrumentation , Mass Screening/instrumentation , User-Computer Interface
11.
Biol Chem ; 379(10): 1289-93, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9820591

ABSTRACT

We describe a polyadenylated RNA (Drld = Differentially regulated in lymphoid organs and differentiation) from murine lymphocytes. Two homologous molecular forms of this RNA of approximately 500 and 900 bases are detected in various tissues and lymphoid cell lines. Southern blotting showed that up to ten highly homologous loci exist which in part are polymorphic between the different mouse strains analyzed. Cross-hybridizing loci can be detected in distantly related species such as horse, fish and Drosophila melanogaster. Sequence analysis revealed homologies to the untranslated region of the GPI-linked murine B7(2) antigen, the B2 repetitive elements and 3 untranslated genes. Drld apparently defines a new family of genetic elements.


Subject(s)
Cloning, Molecular , Conserved Sequence , Lymphocytes/metabolism , RNA, Messenger/genetics , Animals , Base Sequence , Mice , Molecular Sequence Data , Sequence Homology, Nucleic Acid , Species Specificity
12.
Int Immunol ; 10(8): 1197-202, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9723706

ABSTRACT

CD21, the complement receptor type 2 (CR2), binds the complement fragments iC3b, C3dg and C3d, interacts with CD23 (the low-affinity receptor for IgE), and binds IFN-alpha. This 145 kDa glycoprotein merits particular interest because it plays a pivotal role in the activation and proliferation of B cells by lowering the signal threshold. In human disease CD21 is important as a receptor for Epstein-Barr virus and HIV. CD21 is primarily expressed on B lymphocytes and follicular dendritic cells, but has also been reported on T cells. We established a semi-quantitative PCR and compared the CD21 mRNA levels of B and T lymphocytes with the expression of the CD21 glycoprotein on the surface of the respective cells by flow cytometry. The B cell lines Raji and Ramos and the T cell lines Jurkat and Molt4 expressed equal amounts of CD21 mRNA, but differed in surface staining. To address the question to which extent primary human B and T lymphocytes express CD21 mRNA and membrane-bound CD21 glycoprotein, we separated B cells, CD4+ and CD8+ T cells from peripheral blood mononuclear cells of healthy donors. B lymphocytes and CD4+ or CD8+ T cells expressed similar amounts of CD21 mRNA. Nevertheless only B cells, but not CD4+ or CD8+ T cells, expressed detectable amounts of CD21 on their cell surface. Expression of the CD21 exon 11 has been reported being restricted to follicular dendritic cells only. To the contrary, we found that both purified B and T cell subpopulations expressed CD21 mRNA with and without exon 11.


Subject(s)
B-Lymphocytes/immunology , RNA, Messenger/analysis , Receptors, Complement 3d/analysis , Receptors, Complement 3d/genetics , T-Lymphocytes/immunology , Antigens, CD/analysis , Cell Line , Cell Separation , Cells, Cultured , Flow Cytometry , Humans , Lymphocyte Subsets , Protein Isoforms/genetics , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction
13.
Mol Immunol ; 34(10): 683-93, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9430196

ABSTRACT

CD21 is found in a soluble form at low levels in normal human sera and at elevated levels in sera from patients with EBV-associated diseases and B-CLL. Ablation of complement, injection of recombinant soluble CD21 and knock-out of CD21 in mice by gene targeting interfere with T-cell-dependent immune responses, suggesting that in vivo-generated soluble CD21 may exert immunoregulatory functions. Soluble CD21 has a molecular weight of 130,000/135,000, which is equivalent to the entire extracellular domain. Soluble forms of membrane-anchored molecules may be generated by proteolytic cleavage of the extracellular portion or by the exclusion of the hydrophobic transmembrane region via alternative splicing. To delineate whether alternative splicing of CD21 mRNA creates transcripts encoding for the soluble form of CD21 we analyzed by PCR CD21 expression in PBLs, spleen, tonsils, bone marrow and in various cell lines. We found that all CD21 mRNA species contained the transmembrane exons, thus excluding alternative splicing as a factor contributing to the serum pool of soluble CD21. Differential splicing of the CD21 transcription unit has also been suggested for exon 11. Within the CD21 gene exons 3, 7 and 11 have a high degree of homology. However, we found in malignant human cell lines and primary lymphocytes from blood, bone marrow, tonsils and spleen that exon 11, but not exon 3 or 7, is subject to alternative splicing. We cloned and sequenced the intron preceding exon 11 and found that the surrounding splice sites match consensus splice sites. In conclusion, we show that human CD21 exon 11 is alternatively spliced in malignant cell lines of lymphoid origin and in purified lymphocytes from blood, tonsils, bone marrow and spleen. We found that both exon 11 lacking and exon 11 containing transcripts are always coexpressed and the ratio of the two forms is > 1. Moreover, we exclude the possibility that alternative splicing of the transmembrane region is the mechanism leading to soluble CD21.


Subject(s)
Alternative Splicing , RNA Splicing , Receptors, Complement 3d/genetics , Receptors, Complement 3d/metabolism , B-Lymphocytes/metabolism , Base Sequence , Bone Marrow/metabolism , Cells, Cultured/metabolism , Cloning, Molecular , Exons , Humans , Introns , Jurkat Cells/metabolism , Molecular Sequence Data , Palatine Tonsil/metabolism , Polymerase Chain Reaction , RNA, Messenger/metabolism , Sequence Homology, Nucleic Acid , Spleen/metabolism , T-Lymphocytes/metabolism , Transcription, Genetic , Tumor Cells, Cultured/metabolism
15.
J Exp Med ; 183(2): 421-9, 1996 Feb 01.
Article in English | MEDLINE | ID: mdl-8627155

ABSTRACT

Biosynthesis of the immunoglobulin (Ig) receptor components and their assembly were examined in cell lines representative of early stages in human B lineage development. In pro-B cells, the nascent surrogate light chain proteins form a complex that transiently associates in the endoplasmic reticulum with a spectrum of unidentified proteins (40, 60, and 98 kD) and Bip, a heat shock protein family member. Lacking companion heavy chains, the surrogate light chains in pro-B cells do not associate with either the Ig(alpha) or Ig(beta) signal transduction units, undergo rapid degradation, and fail to reach the pro-B cell surface. In pre-B cells, by contrast, a significant portion of the surrogate light chain proteins associate with mu heavy chains, Ig(alpha), and Ig(beta) to form a stable receptor complex with a relatively long half-life. Early in this assembly process, Bip/GRP78, calnexin, GRP94, and a protein of approximately 17 kD differentially bind to the nascent mu heavy chains. The 17-kD intermediate is gradually replaced by the surrogate light chain protein complex, and the Ig(alpha) and Ig(beta) chains bind progressively to the mu heavy chains during the complex and relatively inefficient process of pre-B receptor assembly. The results suggest that, in humans, heavy chain association is essential for surrogate light chain survival and transport to the cell surface as an integral receptor component.


Subject(s)
B-Lymphocytes/immunology , Heat-Shock Proteins , Hematopoietic Stem Cells/immunology , Receptors, Antigen, B-Cell/biosynthesis , Antigens, CD/metabolism , CD79 Antigens , Calcium-Binding Proteins/metabolism , Calnexin , Carrier Proteins/metabolism , Cell Compartmentation , Cell Line , Cell Membrane/metabolism , Endoplasmic Reticulum Chaperone BiP , HSP70 Heat-Shock Proteins/metabolism , Humans , Immunoglobulin Light Chains , Immunoglobulin Light Chains, Surrogate , Membrane Glycoproteins/metabolism , Membrane Proteins/metabolism , Molecular Chaperones/metabolism , Protein Binding , Receptors, Antigen, B-Cell/metabolism
16.
Mol Immunol ; 29(10): 1265-72, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1528195

ABSTRACT

Immunoglobulin class switch recombination is directed to the same switch region on both chromosomes of a B cell by an as yet unknown mechanism. The cytokine interleukin 4 (IL4) targets recombination in activated B lymphocytes to the gamma 1 switch region (s gamma 1). Here we report two DNA-binding-proteins which bind to a sequence 5' of s gamma 1. One protein is B cell specific, while binding of the other one is induced by IL4. These two proteins bind to a region 700 bp upstream of the putative promoter region of the gamma 1 germline transcripts and may be involved in the process of recombination and/or transcription.


Subject(s)
B-Lymphocytes/immunology , Binding Sites/genetics , DNA-Binding Proteins/physiology , Immunoglobulin G/genetics , Immunoglobulin Switch Region/genetics , Interleukin-4/physiology , Animals , Base Sequence , Cells, Cultured , Lymphocyte Depletion , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Recombination, Genetic , Sequence Homology, Nucleic Acid , Transcription, Genetic
17.
Proc Natl Acad Sci U S A ; 82(24): 8653-7, 1985 Dec.
Article in English | MEDLINE | ID: mdl-2934735

ABSTRACT

Three different monoclonal antibody isotypes, IgG1, IgG2b, and IgG2a, were derived by selection of isotype-switch variants from the CO-19-9 hybridoma. All three antibodies retained their binding specificities and affinities and bound to the same epitope--as defined by the anti-idiotype analysis. Availability of gamma 1, gamma 2b, and gamma 2a Ig heavy chain variants directed against the same epitope on the monosialoganglioside antigen permitted detailed analysis of their Fc fragment receptor (FcR) binding affinities, their cytolytic activities (antibody-dependent, macrophage-mediated cytotoxicity) in vitro, and their tumoricidal activities in vivo. Analysis of the binding of three isotypes to the human FcR expressed by U937 cells induced by gamma interferon has shown that only IgG2a proteins bound to high-affinity FcR, but not IgG1 or IgG2b variants. Although all three isotypes were active in the antibody-dependent, macrophage-mediated cytotoxicity assay with murine thioglycolate-elicited macrophages, the IgG2a gave the highest percentage of lysis; similar results were obtained in the same assay with human monocytes as effector cells. In the nude mice experiment, only the IgG2a variant inhibited growth of human colorectal carcinoma, while IgG1 and IgG2b were ineffective. Thus, selection of isotype-switch variants resulted in the conversion of monoclonal antibody from noncytolytic to cytolytic with possible immunotherapeutic application.


Subject(s)
Antibodies, Monoclonal/immunology , Gangliosides/immunology , Immunoglobulin G/classification , Animals , Antibodies, Monoclonal/classification , Antibodies, Monoclonal/isolation & purification , Antibody Affinity , Antibody Specificity , Antibody-Dependent Cell Cytotoxicity , Antigens, Neoplasm/immunology , Colonic Neoplasms/immunology , Humans , Immunoglobulin Idiotypes/immunology , Mice , Mice, Nude , Monocytes/immunology , Neoplasm Transplantation , Receptors, Antigen, B-Cell/immunology , Receptors, Fc/immunology , Receptors, IgG , Rectal Neoplasms/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...